166 related articles for article (PubMed ID: 30321664)
1. Iron quantification in Parkinson's disease using an age-based threshold on susceptibility maps: The advantage of local versus entire structure iron content measurements.
Sethi SK; Kisch SJ; Ghassaban K; Rajput A; Rajput A; Babyn PS; Liu S; Szkup P; Mark Haacke E
Magn Reson Imaging; 2019 Jan; 55():145-152. PubMed ID: 30321664
[TBL] [Abstract][Full Text] [Related]
2. Iron deposition in Parkinson's disease by quantitative susceptibility mapping.
Chen Q; Chen Y; Zhang Y; Wang F; Yu H; Zhang C; Jiang Z; Luo W
BMC Neurosci; 2019 May; 20(1):23. PubMed ID: 31117957
[TBL] [Abstract][Full Text] [Related]
3. Quantitative Susceptibility Mapping in Parkinson's Disease.
Langkammer C; Pirpamer L; Seiler S; Deistung A; Schweser F; Franthal S; Homayoon N; Katschnig-Winter P; Koegl-Wallner M; Pendl T; Stoegerer EM; Wenzel K; Fazekas F; Ropele S; Reichenbach JR; Schmidt R; Schwingenschuh P
PLoS One; 2016; 11(9):e0162460. PubMed ID: 27598250
[TBL] [Abstract][Full Text] [Related]
4. Assessing global and regional iron content in deep gray matter as a function of age using susceptibility mapping.
Liu M; Liu S; Ghassaban K; Zheng W; Dicicco D; Miao Y; Habib C; Jazmati T; Haacke EM
J Magn Reson Imaging; 2016 Jul; 44(1):59-71. PubMed ID: 26695834
[TBL] [Abstract][Full Text] [Related]
5. Region-specific disturbed iron distribution in early idiopathic Parkinson's disease measured by quantitative susceptibility mapping.
He N; Ling H; Ding B; Huang J; Zhang Y; Zhang Z; Liu C; Chen K; Yan F
Hum Brain Mapp; 2015 Nov; 36(11):4407-20. PubMed ID: 26249218
[TBL] [Abstract][Full Text] [Related]
6. Quantifying iron deposition within the substantia nigra of Parkinson's disease by quantitative susceptibility mapping.
An H; Zeng X; Niu T; Li G; Yang J; Zheng L; Zhou W; Liu H; Zhang M; Huang D; Li J
J Neurol Sci; 2018 Mar; 386():46-52. PubMed ID: 29406966
[TBL] [Abstract][Full Text] [Related]
7. Human brain atlas for automated region of interest selection in quantitative susceptibility mapping: application to determine iron content in deep gray matter structures.
Lim IA; Faria AV; Li X; Hsu JT; Airan RD; Mori S; van Zijl PC
Neuroimage; 2013 Nov; 82():449-69. PubMed ID: 23769915
[TBL] [Abstract][Full Text] [Related]
8. Regional High Iron in the Substantia Nigra Differentiates Parkinson's Disease Patients From Healthy Controls.
Ghassaban K; He N; Sethi SK; Huang P; Chen S; Yan F; Haacke EM
Front Aging Neurosci; 2019; 11():106. PubMed ID: 31191294
[No Abstract] [Full Text] [Related]
9. Quantitative assessment of iron deposition in the midbrain using 3D-enhanced T2 star weighted angiography (ESWAN): a preliminary cross-sectional study of 20 Parkinson's disease patients.
Wang C; Fan G; Xu K; Wang S
Magn Reson Imaging; 2013 Sep; 31(7):1068-73. PubMed ID: 23746648
[TBL] [Abstract][Full Text] [Related]
10. Age-dependent changes in brain iron deposition and volume in deep gray matter nuclei using quantitative susceptibility mapping.
Li G; Tong R; Zhang M; Gillen KM; Jiang W; Du Y; Wang Y; Li J
Neuroimage; 2023 Apr; 269():119923. PubMed ID: 36739101
[TBL] [Abstract][Full Text] [Related]
11. Imaging the Nigrosome 1 in the substantia nigra using susceptibility weighted imaging and quantitative susceptibility mapping: An application to Parkinson's disease.
Cheng Z; He N; Huang P; Li Y; Tang R; Sethi SK; Ghassaban K; Yerramsetty KK; Palutla VK; Chen S; Yan F; Haacke EM
Neuroimage Clin; 2020; 25():102103. PubMed ID: 31869769
[TBL] [Abstract][Full Text] [Related]
12. Increase in the iron content of the substantia nigra and red nucleus in multiple sclerosis and clinically isolated syndrome: a 7 Tesla MRI study.
Blazejewska AI; Al-Radaideh AM; Wharton S; Lim SY; Bowtell RW; Constantinescu CS; Gowland PA
J Magn Reson Imaging; 2015 Apr; 41(4):1065-70. PubMed ID: 24841344
[TBL] [Abstract][Full Text] [Related]
13. Quantitative susceptibility mapping of the midbrain in Parkinson's disease.
Du G; Liu T; Lewis MM; Kong L; Wang Y; Connor J; Mailman RB; Huang X
Mov Disord; 2016 Mar; 31(3):317-24. PubMed ID: 26362242
[TBL] [Abstract][Full Text] [Related]
14. Iron Content in Deep Gray Matter as a Function of Age Using Quantitative Susceptibility Mapping: A Multicenter Study.
Li Y; Sethi SK; Zhang C; Miao Y; Yerramsetty KK; Palutla VK; Gharabaghi S; Wang C; He N; Cheng J; Yan F; Haacke EM
Front Neurosci; 2020; 14():607705. PubMed ID: 33488350
[TBL] [Abstract][Full Text] [Related]
15. The whole-brain pattern of magnetic susceptibility perturbations in Parkinson's disease.
Acosta-Cabronero J; Cardenas-Blanco A; Betts MJ; Butryn M; Valdes-Herrera JP; Galazky I; Nestor PJ
Brain; 2017 Jan; 140(1):118-131. PubMed ID: 27836833
[TBL] [Abstract][Full Text] [Related]
16. Quantitative susceptibility mapping as an indicator of subcortical and limbic iron abnormality in Parkinson's disease with dementia.
Li DTH; Hui ES; Chan Q; Yao N; Chua SE; McAlonan GM; Pang SYY; Ho SL; Mak HKF
Neuroimage Clin; 2018; 20():365-373. PubMed ID: 30128274
[TBL] [Abstract][Full Text] [Related]
17. Automatic detection of neuromelanin and iron in the midbrain nuclei using a magnetic resonance imaging-based brain template.
Jin Z; Wang Y; Jokar M; Li Y; Cheng Z; Liu Y; Tang R; Shi X; Zhang Y; Min J; Liu F; He N; Yan F; Haacke EM
Hum Brain Mapp; 2022 Apr; 43(6):2011-2025. PubMed ID: 35072301
[TBL] [Abstract][Full Text] [Related]
18. Motor associations of iron accumulation in deep grey matter nuclei in Parkinson's disease: a cross-sectional study of iron-related magnetic resonance imaging susceptibility.
Martin-Bastida A; Lao-Kaim NP; Loane C; Politis M; Roussakis AA; Valle-Guzman N; Kefalopoulou Z; Paul-Visse G; Widner H; Xing Y; Schwarz ST; Auer DP; Foltynie T; Barker RA; Piccini P
Eur J Neurol; 2017 Feb; 24(2):357-365. PubMed ID: 27982501
[TBL] [Abstract][Full Text] [Related]
19. Differential Effect of Iron and Myelin on Susceptibility MRI in the Substantia Nigra.
Lee H; Cho H; Lee MJ; Kim TH; Roh J; Lee JH
Radiology; 2021 Dec; 301(3):682-691. PubMed ID: 34609198
[TBL] [Abstract][Full Text] [Related]
20. Quantifying brain iron deposition in patients with Parkinson's disease using quantitative susceptibility mapping, R2 and R2.
Barbosa JH; Santos AC; Tumas V; Liu M; Zheng W; Haacke EM; Salmon CE
Magn Reson Imaging; 2015 Jun; 33(5):559-65. PubMed ID: 25721997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
